-
1
-
-
84855296204
-
Novel roles of complement in T effector cell regulation
-
Heeger PS, Kemper C. Novel roles of complement in T effector cell regulation. Immunobiology 2012;217:216-24.
-
(2012)
Immunobiology
, vol.217
, pp. 216-224
-
-
Heeger, P.S.1
Kemper, C.2
-
2
-
-
40249116606
-
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells
-
Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008;28:425-35.
-
(2008)
Immunity
, vol.28
, pp. 425-435
-
-
Strainic, M.G.1
Liu, J.2
Huang, D.3
An, F.4
Lalli, P.N.5
Muqim, N.6
-
3
-
-
84872681454
-
Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells
-
Strainic MG, Shevach EM, An F, Lin F, Medof ME. Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells. Nat Immunol 2013;14:162-71.
-
(2013)
Nat Immunol
, vol.14
, pp. 162-171
-
-
Strainic, M.G.1
Shevach, E.M.2
An, F.3
Lin, F.4
Medof, M.E.5
-
4
-
-
84879087114
-
Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells
-
van der Touw W, Cravedi P, Kwan WH, Paz-Artal E, Merad M, Heeger PS. Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol 2013;190:5921-5.
-
(2013)
J Immunol
, vol.190
, pp. 5921-5925
-
-
Van Der Touw, W.1
Cravedi, P.2
Kwan, W.H.3
Paz-Artal, E.4
Merad, M.5
Heeger, P.S.6
-
5
-
-
84874562997
-
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells
-
Kwan WH, van der Touw W, Paz-Artal E, Li MO, Heeger PS. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med 2013;210:257-68.
-
(2013)
J Exp Med
, vol.210
, pp. 257-268
-
-
Kwan, W.H.1
Van Der Touw, W.2
Paz-Artal, E.3
Li, M.O.4
Heeger, P.S.5
-
6
-
-
52649176344
-
Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis
-
Lalli PN, Strainic MG, Yang M, Lin F, Medof ME, Heeger PS. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 2008;112:1759-66.
-
(2008)
Blood
, vol.112
, pp. 1759-1766
-
-
Lalli, P.N.1
Strainic, M.G.2
Yang, M.3
Lin, F.4
Medof, M.E.5
Heeger, P.S.6
-
7
-
-
84890226478
-
Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation
-
Liszewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, Fara AF, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 2013;39:1143-57.
-
(2013)
Immunity
, vol.39
, pp. 1143-1157
-
-
Liszewski, M.K.1
Kolev, M.2
Le Friec, G.3
Leung, M.4
Bertram, P.G.5
Fara, A.F.6
-
8
-
-
84904015491
-
Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche
-
Vadrevu SK, Chintala NK, Sharma SK, Sharma P, Cleveland C, Riediger L, et al. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. Cancer Res 2014;74:3454-65.
-
(2014)
Cancer Res
, vol.74
, pp. 3454-3465
-
-
Vadrevu, S.K.1
Chintala, N.K.2
Sharma, S.K.3
Sharma, P.4
Cleveland, C.5
Riediger, L.6
-
10
-
-
54549109936
-
Modulation of the antitumor immune response by complement
-
Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, Gerard C, et al. Modulation of the antitumor immune response by complement. Nat Immunol 2008; 9: 1225-35.
-
(2008)
Nat Immunol
, vol.9
, pp. 1225-1235
-
-
Markiewski, M.M.1
Deangelis, R.A.2
Benencia, F.3
Ricklin-Lichtsteiner, S.K.4
Koutoulaki, A.5
Gerard, C.6
-
11
-
-
84867919350
-
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression
-
Corrales L, Ajona D, Rafail S, Lasarte JJ, Riezu-Boj JI, Lambris JD, et al. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J Immunol 2012; 189: 4674-83.
-
(2012)
J Immunol
, vol.189
, pp. 4674-4683
-
-
Corrales, L.1
Ajona, D.2
Rafail, S.3
Lasarte, J.J.4
Riezu-Boj, J.I.5
Lambris, J.D.6
-
12
-
-
84866149234
-
Opposing roles for complement component C5a in tumor progression and the tumor microenvironment
-
Gunn L, Ding C, Liu M, Ma Y, Qi C, Cai Y, et al. Opposing roles for complement component C5a in tumor progression and the tumor microenvironment. J Immunol 2012;189:2985-94.
-
(2012)
J Immunol
, vol.189
, pp. 2985-2994
-
-
Gunn, L.1
Ding, C.2
Liu, M.3
Ma, Y.4
Qi, C.5
Cai, Y.6
-
13
-
-
84899099671
-
Role of the complement system in NK cell-mediated antitumor T-cell responses
-
Janelle V, Lamarre A. Role of the complement system in NK cell-mediated antitumor T-cell responses. Oncoimmunology 2014;3:e27897.
-
(2014)
Oncoimmunology
, vol.3
-
-
Janelle, V.1
Lamarre, A.2
-
14
-
-
79953048089
-
Regulation and functions of the IL-10 family of cytokines in inflammation and disease
-
Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011;29:71-109.
-
(2011)
Annu Rev Immunol
, vol.29
, pp. 71-109
-
-
Ouyang, W.1
Rutz, S.2
Crellin, N.K.3
Valdez, P.A.4
Hymowitz, S.G.5
-
15
-
-
0025820460
-
IL-10: A novel cytotoxic T cell differentiation factor
-
Chen WF, Zlotnik A. IL-10: A novel cytotoxic T cell differentiation factor. J Immunol 1991;147:528-34.
-
(1991)
J Immunol
, vol.147
, pp. 528-534
-
-
Chen, W.F.1
Zlotnik, A.2
-
16
-
-
0032055224
-
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells
-
Groux H, Bigler M, de Vries JE, Roncarolo MG. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol 1998;160:3188-93.
-
(1998)
J Immunol
, vol.160
, pp. 3188-3193
-
-
Groux, H.1
Bigler, M.2
De Vries, J.E.3
Roncarolo, M.G.4
-
17
-
-
0033997779
-
Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes
-
Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Roman JJ, et al. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J Virol 2000;74:4729-37.
-
(2000)
J Virol
, vol.74
, pp. 4729-4737
-
-
Santin, A.D.1
Hermonat, P.L.2
Ravaggi, A.3
Bellone, S.4
Pecorelli, S.5
Roman, J.J.6
-
18
-
-
0029094021
-
In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation
-
Yang G, Hellstrom KE, Mizuno MT, Chen L. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J Immunol 1995;155:3897-903.
-
(1995)
J Immunol
, vol.155
, pp. 3897-3903
-
-
Yang, G.1
Hellstrom, K.E.2
Mizuno, M.T.3
Chen, L.4
-
19
-
-
0029951658
-
Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice
-
Berman RM, Suzuki T, Tahara H, Robbins PD, Narula SK, Lotze MT. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. J Immunol 1996;157:231-8.
-
(1996)
J Immunol
, vol.157
, pp. 231-238
-
-
Berman, R.M.1
Suzuki, T.2
Tahara, H.3
Robbins, P.D.4
Narula, S.K.5
Lotze, M.T.6
-
20
-
-
0035496946
-
Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ
-
Fujii S, Shimizu K, Shimizu T, Lotze MT. Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ. Blood 2001;98:2143-51.
-
(2001)
Blood
, vol.98
, pp. 2143-2151
-
-
Fujii, S.1
Shimizu, K.2
Shimizu, T.3
Lotze, M.T.4
-
21
-
-
83455173552
-
IL-10 elicits IFNgamma-dependent tumor immune surveillance
-
Mumm JB, Emmerich J, Zhang X, Chan I, Wu L, Mauze S, et al. IL-10 elicits IFNgamma-dependent tumor immune surveillance. Cancer Cell 2011;20:781-96.
-
(2011)
Cancer Cell
, vol.20
, pp. 781-796
-
-
Mumm, J.B.1
Emmerich, J.2
Zhang, X.3
Chan, I.4
Wu, L.5
Mauze, S.6
-
22
-
-
84863973465
-
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs
-
Emmerich J, Mumm JB, Chan IH, LaFace D, Truong H, McClanahan T, et al. IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs. Cancer Res 2012;72:3570-81.
-
(2012)
Cancer Res
, vol.72
, pp. 3570-3581
-
-
Emmerich, J.1
Mumm, J.B.2
Chan, I.H.3
Laface, D.4
Truong, H.5
McClanahan, T.6
-
23
-
-
0346895107
-
Possible contribution of circulating interleukin-10 (IL-10) to antitumor immunity and prognosis in patients with unresectable hepatocellular carcinoma
-
Hattori E, Okumoto K, Adachi T, Takeda T, Ito J, Sugahara K, et al. Possible contribution of circulating interleukin-10 (IL-10) to antitumor immunity and prognosis in patients with unresectable hepatocellular carcinoma. Hepatol Res 2003;27:309-14.
-
(2003)
Hepatol Res
, vol.27
, pp. 309-314
-
-
Hattori, E.1
Okumoto, K.2
Adachi, T.3
Takeda, T.4
Ito, J.5
Sugahara, K.6
-
24
-
-
84887462082
-
Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
-
Stewart CA, Metheny H, Iida N, Smith L, Hanson M, Steinhagen F, et al. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation. J Clin Invest 2013;123:4859-74.
-
(2013)
J Clin Invest
, vol.123
, pp. 4859-4874
-
-
Stewart, C.A.1
Metheny, H.2
Iida, N.3
Smith, L.4
Hanson, M.5
Steinhagen, F.6
-
25
-
-
84912089439
-
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells
-
Ruffell B, Chang-Strachan D, Chan V, Rosenbusch A, Ho CM, Pryer N, et al. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell 2014;26:623-37.
-
(2014)
Cancer Cell
, vol.26
, pp. 623-637
-
-
Ruffell, B.1
Chang-Strachan, D.2
Chan, V.3
Rosenbusch, A.4
Ho, C.M.5
Pryer, N.6
-
26
-
-
79953222926
-
Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus induced encephalitis
-
Trandem K, Zhao J, Fleming E, Perlman S. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus induced encephalitis. J Immunol 2011;186:3642-52.
-
(2011)
J Immunol
, vol.186
, pp. 3642-3652
-
-
Trandem, K.1
Zhao, J.2
Fleming, E.3
Perlman, S.4
-
27
-
-
33845453812
-
Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse
-
Kamanaka M, Kim ST, Wan YY, Sutterwala FS, Lara-Tejero M, Galan JE, et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 2006;25:941-52.
-
(2006)
Immunity
, vol.25
, pp. 941-952
-
-
Kamanaka, M.1
Kim, S.T.2
Wan, Y.Y.3
Sutterwala, F.S.4
Lara-Tejero, M.5
Galan, J.E.6
-
28
-
-
0029558338
-
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
-
Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 1995;92:11490-4.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 11490-11494
-
-
Wessels, M.R.1
Butko, P.2
Ma, M.3
Warren, H.B.4
Lage, A.L.5
Carroll, M.C.6
-
29
-
-
0026485046
-
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages
-
Mombaerts P, Clarke AR, Rudnicki MA, Iacomini J, Itohara S, Lafaille JJ, et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 1992;360:225-31.
-
(1992)
Nature
, vol.360
, pp. 225-231
-
-
Mombaerts, P.1
Clarke, A.R.2
Rudnicki, M.A.3
Iacomini, J.4
Itohara, S.5
Lafaille, J.J.6
-
30
-
-
0027521572
-
Interleukin-10-deficient mice develop chronic enterocolitis
-
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75: 263-74.
-
(1993)
Cell
, vol.75
, pp. 263-274
-
-
Kuhn, R.1
Lohler, J.2
Rennick, D.3
Rajewsky, K.4
Muller, W.5
-
31
-
-
0035873782
-
Identifi cation of a selective nonpeptide antagonist of theanaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models
-
Ames RS, Lee D, Foley JJ, Jurewicz AJ, Tornetta MA, Bautsch W, et al. Identifi cation of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol 2001;166:6341-8.
-
(2001)
J Immunol
, vol.166
, pp. 6341-6348
-
-
Ames, R.S.1
Lee, D.2
Foley, J.J.3
Jurewicz, A.J.4
Tornetta, M.A.5
Bautsch, W.6
-
32
-
-
0038441460
-
A convergent solution- phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp-Arg], a potent new antiinflammatory drug
-
Reid RC, Abbenante G, Taylor SM, Fairlie DP. A convergent solution- phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp-Arg], a potent new antiinflammatory drug. J Org Chem 2003;68:4464-71.
-
(2003)
J Org Chem
, vol.68
, pp. 4464-4471
-
-
Reid, R.C.1
Abbenante, G.2
Taylor, S.M.3
Fairlie, D.P.4
-
33
-
-
84862859820
-
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
-
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012;366:2443-54.
-
(2012)
N Engl J Med
, vol.366
, pp. 2443-2454
-
-
Topalian, S.L.1
Hodi, F.S.2
Brahmer, J.R.3
Gettinger, S.N.4
Smith, D.C.5
McDermott, D.F.6
-
34
-
-
0032736029
-
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
-
Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999;5:1365-9.
-
(1999)
Nat Med
, vol.5
, pp. 1365-1369
-
-
Dong, H.1
Zhu, G.2
Tamada, K.3
Chen, L.4
-
35
-
-
84867544962
-
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-gamma inducible chemokines
-
Peng W, Liu C, Xu C, Lou Y, Chen J, Yang Y, et al. PD-1 blockade enhances T-cell migration to tumors by elevating IFN-gamma inducible chemokines. Cancer Res 2012;72:5209-18.
-
(2012)
Cancer Res
, vol.72
, pp. 5209-5218
-
-
Peng, W.1
Liu, C.2
Xu, C.3
Lou, Y.4
Chen, J.5
Yang, Y.6
-
36
-
-
84860338659
-
C5aR expression in a novel GFP reporter gene knockin mouse: Implications for the mechanism of action of C5aR signaling in T cell immunity
-
Dunkelberger J, Zhou L, Miwa T, Song WC. C5aR expression in a novel GFP reporter gene knockin mouse: implications for the mechanism of action of C5aR signaling in T cell immunity. J Immunol 2012;188:4032-42.
-
(2012)
J Immunol
, vol.188
, pp. 4032-4042
-
-
Dunkelberger, J.1
Zhou, L.2
Miwa, T.3
Song, W.C.4
-
37
-
-
84897077965
-
Autocrine effects of tumor-derived complement
-
Cho MS, Vasquez HG, Rupaimoole R, Pradeep S, Wu S, Zand B, et al. Autocrine effects of tumor-derived complement. Cell Rep 2014; 6: 1085-95.
-
(2014)
Cell Rep
, vol.6
, pp. 1085-1095
-
-
Cho, M.S.1
Vasquez, H.G.2
Rupaimoole, R.3
Pradeep, S.4
Wu, S.5
Zand, B.6
-
38
-
-
33744987414
-
Generation of C5a in the absence of C3: A new complement activation pathway
-
Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al. Generation of C5a in the absence of C3: A new complement activation pathway. Nat Med 2006;12:682-7.
-
(2006)
Nat Med
, vol.12
, pp. 682-687
-
-
Huber-Lang, M.1
Sarma, J.V.2
Zetoune, F.S.3
Rittirsch, D.4
Neff, T.A.5
McGuire, S.R.6
-
39
-
-
0029813545
-
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
-
Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996;98:1010-20.
-
(1996)
J Clin Invest
, vol.98
, pp. 1010-1020
-
-
Berg, D.J.1
Davidson, N.2
Kuhn, R.3
Muller, W.4
Menon, S.5
Holland, G.6
-
40
-
-
84862908564
-
Interleukin-10 ablation promotes tumor development, growth, and metastasis
-
Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao J, Nunez G, et al. Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res 2012;72:420-9.
-
(2012)
Cancer Res
, vol.72
, pp. 420-429
-
-
Tanikawa, T.1
Wilke, C.M.2
Kryczek, I.3
Chen, G.Y.4
Kao, J.5
Nunez, G.6
-
41
-
-
84944453893
-
IL-10 enhances CTL- mediated tumor rejection by inhibiting highly suppressive CD4 T cells and promoting CTL persistence in a murine model of plasmacytoma
-
Wang L, Liu JQ, Talebian F, Liu Z, Yu L, Bai XF. IL-10 enhances CTL- mediated tumor rejection by inhibiting highly suppressive CD4 T cells and promoting CTL persistence in a murine model of plasmacytoma. Oncoimmunology 2015;4:e1014232.
-
(2015)
Oncoimmunology
, vol.4
-
-
Wang, L.1
Liu, J.Q.2
Talebian, F.3
Liu, Z.4
Yu, L.5
Bai, X.F.6
-
42
-
-
85012033668
-
Avoiding bad complement in Alzheimer's disease
-
Flight MH. Avoiding bad complement in Alzheimer's disease. Nat Rev Neurosci 2009;8:316.
-
(2009)
Nat Rev Neurosci
, vol.8
, pp. 316
-
-
Flight, M.H.1
-
43
-
-
84858766182
-
The blockade of immune checkpoints in cancer immunotherapy
-
Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12:252-64.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 252-264
-
-
Pardoll, D.M.1
-
44
-
-
84902191817
-
IL-2: The first effective immunotherapy for human cancer
-
Rosenberg SA. IL-2: The first effective immunotherapy for human cancer. J Immunol 2014;192:5451-8.
-
(2014)
J Immunol
, vol.192
, pp. 5451-5458
-
-
Rosenberg, S.A.1
|